Paul Doran, strategic alliance manager, Cellular Dynamics
James Drees, sales enablement manager, Seagate Technology
Jorg Drenkow, research associate, Cold Spring Harbor Laboratory
Mark Dronsfield, European sales director, RainDance Technologies
Kevin Dunne, clinical and pharma specialist, Complete Genomics
Ann Edwards, senior human resources manager, Takeda San Francisco
Nancy Ellington, senior director of compensation, benefits and HRIS, Intellectual Ventures
Robert Ellis, consultant [Added: 11:50 am PT, 5/2/12]
Nicole Ellis Ovadia, senior product manager, global commercial platforms, BD Biosciences
Malek Faham, chief scientific officer, Sequenta
Hossein Fakhrai-Rad, founder and CEO, Genophen
Mat Falkowski, director, Skukuru
Patrizia Fazeli, senior marcom specialist, Agilent Technologies
Gregg Fergus, president and COO, Ion Torrent Systems (part of Life Technologies)
Jacqueline Fidanza, senior manager of manufacturing, Ion Torrent Systems
Curtis Fideler, director sales manager, Illumina
Sandra Finley, vice president of strategic marketing, Aviir
Jeff Fitzgerald, director of business development, Expression Analysis
Stephen Fodor, chairman of the board, Affymetrix [Added: 10:30 am, 5/3/12]
David Fullerton, senior R&D engineering technician, RainDance Technologies
Hana Gage, commercial director, Pacific Asia & Latin America, Fluidigm
Amy Gannaway, senior director, WW HRIS, VMware
Matthew Garrett, chief financial officer, Navigenics
Erik Gentalen, director of product support, ProteinSimple
Srinka Ghosh, senior bioinformatics applications manager, Complete Genomics
Martin Goldberg, chief operating officer, Gen9 [Added: 11:50 am PT, 5/2/12]
Stu Grabar, director of manufacturing, T2 Biosystems
Anthony Green, senior translational genomics specialist, Illumina
Jeff Gruszynski, principal, director of R&D, Core Wafer Systems
Cyrus Harmon, CEO, Olema Pharmaceuticals
Richard Henfrey, associate director of marketing in Europe, Illumina
Christian Henry, chief financial officer, Illumina
Lucas Hickey, associate director of sales and market development, PacBio
Steve Holmes, counsel, Kaye Scholer [Added: 10:30 am, 5/3/12]
